Homayoun Bagherinia Carl Zeiss Meditec, Inc., Code E (Employment);
Luis De Sisternes None;
Jie Lu None;
Yingying Shi None;
Philip Rosenfeld Annexon, Apellis, Bayer, Boehringer-Ingelheim, Carl Zeiss Meditec, Chengdu Kanghong Biotech, InflammX, Ocudyne, Regeneron, Unity Biotechnology, Code C (Consultant/Contractor), Alexion, Carl Zeiss Meditec, Gyroscope Therapeutics, Stealth BioTherapeutics, Code F (Financial Support), Apellis, Ocudyne, Valitor, Verana Health, Code I (Personal Financial Interest);
Ruikang Wang Carl Zeiss Meditec, Inc., Code C (Consultant/Contractor), Carl Zeiss Meditec, Colgate Palmolive Company, Estee Lauder Inc, Code F (Financial Support), US8,750,586, US8,180,134, US9,282,905, US9,759,544, US 10,354,378, US10,529,061, Code P (Patent)